BDR Pharma buys majority stake in Acme’s oral solids formulations business
Existing investors, including private equity firm PAG, are selling their stakes in Acme's oral solids formulations business in a transaction that is expected to value the business at about $250 million.
What's Your Reaction?
Like
0
Dislike
0
Love
0
Funny
0
Wow
0
Sad
0
Angry
0
Comments (0)